COMP <GO>
ARGX vs AMGN // EV/EBITDA & P/E VALUATION
argenx SE (NASDAQ) VS. Amgen Inc. (NASDAQ) • 15-METRIC TALLY: ARGX 4
— AMGN 8
▲ EV/EBITDA & P/E VALUATION LEADER: ARGX
LAST: $892.87 (-0.56%) • MKT CAP: $55.72B
valuation
21.0x
LAST: $466.01 (+1.15%) • MKT CAP: $249.09B
valuation
27.2x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ARGX VS. AMGN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ARGX | AMGN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 67.20% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.90% | 14.50% | -4.60 | AMGN | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 21.0x | 27.2x | -6.20 | ARGX | /valuation <GO> |
| Free Cash Flow Yield | 2.21% | 3.25% | -1.04 | AMGN | /fcf-yield <GO> |
| Operating Margin | 13.90% | 24.70% | -10.80 | AMGN | /operating-margins <GO> |
| Net Profit Margin | 10.90% | 21.00% | -10.10 | AMGN | /net-margins <GO> |
| Revenue Growth (YoY) | 18.70% | 10.00% | +8.70 | ARGX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.06% | -2.06 | AMGN | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.74 | 3.83 | -0.09 | AMGN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.7 | 67.0 | -15.30 | AMGN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.02 | 0.87 | +0.15 | ARGX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 27.6x | 30.0x | -2.40 | ARGX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $55.72B | $249.09B | -$193.36B | AMGN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ARGX REV | AMGN REV | ARGX GROSS % | AMGN GROSS % | ARGX FCF | AMGN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $36.75B | — | 67.2% | — | $8.10B |
| FY 2024 | — | $33.42B | — | 61.5% | — | $10.39B |
| FY 2023 | — | $28.19B | — | — | — | $7.20B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ARGX // BETA 1.02
AMGN // BETA 0.87